12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
MorphoSys (NASDAQ:MOR) stock moved upwards by 15.07% to $16.26 during Thursday's after-market session. The market value of their outstanding shares is at $2.2 billion.
Enochian Stock Is Trading Higher On FDA Acceptance of Pre-IND Request For Hepatitis B Program
Enochian BioSciences Inc (NASDAQ:ENOB) has announced that the FDA has accepted a Pre-IND (Investigational New Drug) request for a potential cure…
Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection
Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that the FDA has accepted a Pre-IND (Investigational New Drug) request for a
Enochian BioSciences Highlights Scientific Presentation Of Elimination Of HBV In Mice With No Evident Toxicity
(NASDAQ:ENOB) – Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that Dr. Serhat Gumrukçu, co-founder and
Why Enochian Biosciences, Raven Industries And GE Share Are Trading Higher Today
Enochian Biosciences Inc (NASDAQ: ENOB) shares are trading higher by 11.7% at $6.48 Monday morning after the company announced it acquired an exclusive license for an innovative technology to potentially treat and prevent all variants of coronavirus, including the cause of COVID-19, as well as influenza.
Enochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treatment and Prevention Technology
Enochian BioSciences, Inc., a company focused on gene-modified cellular and immune therapies in infectious diseases and cancer, today announced that the company has acquired an exclusive license for an innovative